Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Hadley Wood, MD, is Staff in Cleveland Clinic’s Center for Genitourinary Reconstruction, part of the Glickman Urological and Kidney Institute and Assistant Professor of Surgery, Case-Lerner College of Medicine.
Dr. Wood completed her undergraduate degree at Duke University in Durham, North Carolina. She earned her medical degree from Johns Hopkins University School of Medicine in Baltimore. Her post-graduate training includes a urology residency with Cleveland Clinic Glickman Urological and Kidney Institute in Cleveland.
Dr. Wood is a fellow of the American College of Surgeons and member of the American Board of Urology, American Urological Association, Society for Women in Urology, Societe Internationale Urologie and Society of Genitourinary Reconstructive Surgeons.
Dr. Wood has received several research grants and has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings. She received the Bruce Hubbard Stewart Award for Humanistic Medicine (2008) and serves on the Cleveland Clinic Professionalism Council.
Her specialty interests include genital and urinary reconstruction with a special focus on adolescents and adults with congenital anomalies of the genitourinary tract. These include: myelomeningocele, hypospadias, bladder exstrophy, Eagle Barrett syndrome, ambiguous genitalia, neurogenic bladder, as well as many others. She also treats acquired urological reconstructive problems, including radiation fistulae, urethral strictures, operative injuries to the bladder and ureters, and traumatic bladder and genital injuries.
Genitourinary reconstruction, congenital anomalies of the genitalia and bladder, penile cancer, penile curvature, peyronie's disease, urethral strictures, neurogenic bladder, myelodysplastic syndrome (MDS), spina bifida, urinary incontinence
Awards & Honors
Bruce Hubbard Stewart Award (2008)- humanistic medicine
Elisabeth Pickett Award (2007)- urological research
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/25/2014, Dr. Wood has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.